Quintessence Biosciences, Inc.

Who is Quintessence Biosciences?

What is the EVade™ Ribonuclease Technology?

How was the EVade™ Ribonuclease Technology Discovered?

Quintessence Biosciences, Inc.
505 South Rosa Road
Madison, Wisconsin 53719 USA
Phone: +1-608.441.2950
Fax: +1-608.441.2952

Management

Business Board

Science Board

Careers

Science Board

The Scientific Advisory Board (SAB) includes the company founders, Professors Ronald Raines and Laura Kiessling, as well as two oncologists at the University of Wisconsin Carbone Cancer Center, Doctors Howard Bailey and Paul Sondel. The SAB is chaired by Company President Laura Strong.

Howard H. Bailey, M.D.

Dr. Bailey graduated from the University of North Dakota Medical School and received his Internal Medicine training at Kalamazoo, Michigan. He performed fellowship training in Medical Oncology at the University of Wisconsin as well as a Research Fellowship at the University of Wisconsin Comprehensive Cancer Center. He has been a faculty member of the University of Wisconsin Medical School since 1994 and currently is a Professor of Medicine and Obstetrics and Gynecology. Dr. Bailey is a past Vice Chair in the Department of Medicine and a past Associate Director of the UW Comprehensive Cancer Center. In addition to a long history of leading federally- and industry-sponsored cancer clinical trials he has developed and led multiple regional/national research networks. His clinical and research expertise is focused on the development of novel agents for the treatment or prevention of cancers.

Dr. Laura L. Kiessling, Founder

Dr. Kiessling, a founder of the Company, is a leading expert on the chemistry and biology of nucleic acids and carbohydrates. After receiving a Ph.D. degree in Organic Chemistry from Yale University, Dr. Kiessling did postdoctoral work in chemistry at the California Institute of Technology. In 1991, she joined the faculty at the University of Wisconsin-Madison, where she is now a Hilldale Professor of Chemistry and Biochemistry and the Laurens Anderson Professor of Biochemistry. Dr. Kiessling serves as a consultant for numerous pharmaceutical and biotechnology companies.
Dr. Kiessling is Editor-In-Chief of ACS Chemical Biology, and she has served on numerous Editorial Boards including the boards of the scientific journals Chemistry & Biology, the Journal of the American Chemical Society, and the Annual Reviews of Biochemistry. She has received numerous national awards for her research. Dr. Kiessling received in 1999 a MacArthur Fellowship for the discovery of the Neobiopolymer TM technology, the Arthur C. Cope Scholar Award in Organic Chemistry, and the Horace Isbell Award in Carbohydrates from the American Chemical Society. She also is a recipient of the Harrison Howe Award (2004), the Garvan Award (2007), the Wilbur Cross Medal from Yale University (2008), She is a member of the American Association of Arts and Sciences and the National Academy of Sciences.

Dr. Ronald T. Raines, Founder

Dr. Raines, a founder of the Company, is a leading expert on the chemistry and biology of proteins. Dr. Raines received A.M. and Ph.D. degrees in organic chemistry from Harvard University and did postdoctoral research in biochemistry and biophysics at the University of California, San Francisco. In 1989, he joined the faculty at the University of Wisconsin–Madison, where he is now the Henry Lardy Professor of Biochemistry and a Professor of Chemistry. Dr. Raines has served as a Scientific Advisory Board member or consultant for numerous pharmaceutical and biotechnology companies. He has been a Visiting Scientist at Chiron Corporation as well as a Visiting Associate at Caltech. He is on the editorial advisory boards of ACS Chemical Biology; Peptide Science; Protein Engineering, Design, and Selection; and Protein Science; and on the scientific advisory board of the Keystone Symposia. Dr. Raines is an author of over 200 scientific articles and has won national and international awards for his research, including the Pfizer Award in Enzyme Chemistry, the Arthur C. Cope Scholar Award in Organic Chemistry, the Repligen Award in Biological Chemistry from the American Chemical Society, the Emil Thomas Kaiser Award from the Protein Society, and a Guggenheim Fellowship. He is a fellow of the American Association for the Advancement of Science and the Royal Society of Chemistry. Dr. Raines is the inventor of the S-TAG™ technology, which is marketed by EMD Chemicals.

Paul M. Sondel, M.D., Ph.D.

Dr. Sondel received a Ph.D. in genetics at the University of Wisconsin-Madison. He graduated from Harvard Medical School and did an internship at the University of Minnesota Hospital. Dr. Sondel then did his residency in the Department of Pediatrics at the University of Wisconsin-Madison. He has been a faculty member of the University of Wisconsin Medical School since 1980. He currently is Walker Professor in the Departments of Pediatrics and Human Oncology at UW Medical School where he is the head of the Division of Pediatric Hematology-Oncology. He has co-authored over 300 publications. Dr. Sondel does research related to immune modulation as treatment for malignancy.